Iceland - Renin-Angiotensin System Medicine Use
Since 2014, Iceland Renin-Angiotensin System Medicine Use rose 2.1% year on year. At 135.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 21 among other countries in Renin-Angiotensin System Medicine Use. Iceland is overtaken by Austria, which was ranked number 20 at 143.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Australia at 125.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Hungary topped the ranking with 369.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, +0.6% compared to 2018. Germany, Czech Republic and Finland respectively ranked number 2, 3 and 4 in this ranking. Austria recorded the best 5 years average growth at +10.2% per year, while Chile witnessed the worst performance at -3.5% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 135.30 |
2018 | 135.10 |
2017 | 130.50 |
2016 | 128.40 |
2015 | 125.40 |
How does Iceland rank in Renin-Angiotensin System Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Hungary
|
370 | 2019 | +0.6 % | +0.6 % | View data | |
2 |
#2
Germany
|
358 | 2019 | +3.4 % | +1.7 % | View data | |
20 |
#20
Austria
|
144 | 2019 | +0.8 % | +10.2 % | View data | |
21 |
#21
Iceland
|
135 | 2019 | +0.1 % | +2.1 % | View data | |
22 |
#22
Australia
|
126 | 2019 | +1.1 % | -1.0 % | View data |